A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

Completed

• Conditions: Glaucoma, Open-Angle
• Interventions: Other: Standard of Care

• Registration Number: NCT01629407
• Lead Sponsor: Allergan

Brief Summary

This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-06
• Study First Submitted: 2012-06-25
• Study First Submitted QC: 2012-06-25
• Study First Posted: 2012-06-27
• Primary Completion: 2013-05
• Study Completion: 2013-05
• Status Verified: 2013-06
• Last Update Submitted: 2013-06-19
• Last Update Posted: 2013-06-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 315

Inclusion Criteria

• Glaucoma in one or both eyes

Exclusion Criteria

• Participation in a glaucoma therapeutic clinical trial

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Glaucoma	Standard of Care	Patients with glaucoma

Primary Outcome Measures

Name	Time	Method
Change from Baseline in Visual Field	Baseline, 24 Months

Secondary Outcome Measures

Name	Time	Method
Change from Baseline in Intraocular Pressure (IOP)	Baseline, 24 Months